Intimatioin for Closure of Trading Window for Financial Resilt for March 31,2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kobo Biotech Limited has informed BSE that the trading window for insiders will remain closed from April 1, 2026, until 48 hours after the declaration of audited financial results for Q4 and the full financial year ending March 31, 2026. This is a standard compliance step under SEBI's Insider Trading Regulations to prevent insiders from trading while in possession of unpublished financial information. The company is currently under the Corporate Insolvency Resolution Process (CIRP), and the letter is signed by Resolution Professional Namrata Amol Randeri instead of regular management. The date of the Board meeting to consider and approve the audited results will be communicated separately.
This is a routine procedural filing and is unlikely to directly move the stock price. Investors should continue to factor in that the company remains under CIRP, which remains the key driver of any investment outcome.